A newly developed high-performance thin layer chromatographic method for determination of remdesivir, favipiravir and dexamethasone, in spiked human plasma: comparison with the published methods
Abstract Co-administration of COVID-19 RNA polymerase inhibitors, remdesivir and favipiravir, has synergistic benefits. Together they reduce viral load and inflammation more effectively than either drug used alone. Corticosteroids like dexamethasone are used alongside antivirals in multidrug combina...
Saved in:
| Main Authors: | Rehab M. Abdelfatah, Esraa H. Abdelmomen, Eglal A. Abdelaleem, Refaat H. Abdelmoety, Aml A. Emam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | BMC Chemistry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13065-024-01366-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thyrotoxicosis antidote assay along with concurrent medication; chromatographic and environmental issues
by: Raghda A. Emam, et al.
Published: (2025-05-01) -
Application of seven tools for evaluation of greenness of chromatographic methods for Remdesivir analysis
by: Aesha Bhalodia, et al.
Published: (2024-12-01) -
Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma
by: Amal B. Ahmed, et al.
Published: (2025-01-01) -
Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters
by: Megan Neary, et al.
Published: (2024-11-01) -
Recent Optical Coherence Tomography (OCT) Innovations for Increased Accessibility and Remote Surveillance
by: Brigid C. Devine, et al.
Published: (2025-04-01)